Avidity Biosciences Total Liabilities 2019-2022 | RNA

Avidity Biosciences total liabilities from 2019 to 2022. Total liabilities can be defined as the total value of all possible claims against the corporation.
Avidity Biosciences Annual Total Liabilities
(Millions of US $)
2021 $46
2020 $28
2019 $28
2018 $0
Avidity Biosciences Quarterly Total Liabilities
(Millions of US $)
2022-03-31 $45
2021-12-31 $46
2021-09-30 $31
2021-06-30 $26
2021-03-31 $29
2020-12-31 $28
2020-09-30 $26
2020-06-30 $25
2020-03-31 $0
2019-12-31
2019-09-30 $0
2019-06-30 $0
2018-12-31 $0
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.728B $0.009B
Avidity Biosciences Inc. is a biopharmaceutical company pioneering a new class of oligonucleotide-based therapies called Antibody Oligonucleotide Conjugates(TM). The company's AOC platform design, engineer and develop therapeutics which combine the tissue selectivity of monoclonal antibodies and the precision of oligonucleotide therapies. Its lead product candidate consist AOC 1001, is designed to treat myotonic dystrophy type 1,and other muscle programs are focused on the treatment of muscle atrophy, Duchenne muscular dystrophy, facioscapulohumeral muscular dystrophy and Pompe disease. Avidity Biosciences Inc. is based in SAN DIEGO.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $162.107B 9.86
Bio-Rad Laboratories (BIO.B) United States $15.121B 32.79
QIAGEN (QGEN) Netherlands $10.761B 16.99
Biohaven Pharmaceutical Holding (BHVN) United States $10.111B 0.00
Ginkgo Bioworks Holdings (DNA) United States $5.648B 0.00
Emergent Biosolutions (EBS) United States $1.770B 7.57
Arcus Biosciences (RCUS) United States $1.376B 34.89
Myovant Sciences (MYOV) United Kingdom $1.033B 0.00
Zymeworks (ZYME) Canada $0.397B 0.00
Gelesis Holdings (GLS) United States $0.345B 0.00
Ambrx Biopharma (AMAM) United States $0.157B 0.00
Enzo Biochem (ENZ) United States $0.110B 22.60
SQZ Biotechnologies (SQZ) United States $0.100B 0.00
ADC Therapeutics SA (ADCT) Switzerland $0.000B 0.00